Rapid and scalable detection of synthetic mRNA byproducts using polynucleotide phosphorylase and polythymidine

Francis Combes1, Thanh-Huong Bui1, Frida J Pettersson1

  • 1Department of Biotechnology and Nanomedicine, SINTEF, Trondheim, Norway.

RNA Biology
|June 5, 2024
PubMed

Insights

Degradation during mRNA production impacts vaccine efficacy. A new enzymatic assay using polynucleotide phosphorylase (PNPase) quickly and sensitively measures mRNA integrity, offering a scalable alternative to existing methods.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Analytical Chemistry

Background:

  • Synthetic messenger RNA (mRNA) production and storage can generate byproducts that compromise vaccine and therapeutic integrity and functionality.
  • mRNA integrity is a critical quality attribute requiring advanced analytical evaluation before clinical application.

Purpose of the Study:

  • To demonstrate the impact of heat degradation on mRNA translatability.
  • To introduce a novel enzymatic assay for assessing the integrity of conventional and self-amplifying mRNA.

Main Methods:

  • Hybridization of oligo-T to the poly(A) tail of intact mRNA.
  • Digestion of unhybridized RNA fragments using a 3'-5' exoribonuclease.
  • Conversion of released adenosine-containing nucleotides to ATP and detection via luminescence.
  • Development of a polynucleotide phosphorylase (PNPase)-based assay for mRNA byproduct detection.

Main Results:

  • The study quantifies the effect of heat degradation on mRNA translatability.
  • A sensitive luminescence-based method was established to detect mRNA byproducts.
  • The novel PNPase assay provides fast and sensitive mRNA integrity evaluation across different mRNA lengths.

Conclusions:

  • The developed enzymatic assay is a sensitive and scalable method for evaluating mRNA integrity.
  • This PNPase-based approach offers a viable alternative to traditional chromatographic, electrophoresis, or sequencing techniques for mRNA quality control.